Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Janssen Pharma launches new formulation of darunavir in Japan

Nov. 29, 2013

Viriom expands licensing agreement with Roche for VM-1500

Nov. 20, 2013

European approval for Vitekta

Nov. 19, 2013

Yale University reports discovery of cytotoxic-drug-delivering molecules for HIV

Nov. 18, 2013

Hetero Research Foundation divulges new antiviral agents

Nov. 14, 2013

Gilead Sciences synthesizes new agents for HIV infection

Nov. 8, 2013

ViiV Healthcare files single-tablet regimen MAA for people living with HIV

Oct. 28, 2013

ViiV Healthcare submits NDA for single-tablet HIV regimen

Oct. 24, 2013

Novel gp41 peptide mimetics for HIV infection

Oct. 16, 2013

Janssen files MAA with EMA for fixed-dose combination of darunavir and cobicistat

Oct. 15, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...